<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>80(5)</volume><submitter>Lai CL</submitter><pubmed_abstract>&lt;h4>Aims&lt;/h4>This study aimed to evaluate the risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy using the National Health Insurance claims database, Taiwan, with a self-controlled case series design.&lt;h4>Methods&lt;/h4>All male beneficiaries aged over 50 years as of 2007, who were incident users of α-adrenoceptor blockers and also had a diagnosis of hip/femur fracture within the 2007-2009 study period were identified. The first day when the α-adrenoceptor blocker was prescribed was set as the index date. We partitioned the initial 21 day period following the index date as the post-exposure risk period 1, days 22-60 after the index date as the post-exposure risk period 2, the 21 day period prior to the index date as the pre-exposure risk period 1 and day</pubmed_abstract><journal>British journal of clinical pharmacology</journal><pagination>1208-18</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4631193</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy among elderly males: a self-controlled case series study.</pubmed_title><pmcid>PMC4631193</pmcid><pubmed_authors>Chen MF</pubmed_authors><pubmed_authors>Lai CL</pubmed_authors><pubmed_authors>Lai MS</pubmed_authors><pubmed_authors>Chan KA</pubmed_authors><pubmed_authors>Kuo RN</pubmed_authors><pubmed_authors>Chen HM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy among elderly males: a self-controlled case series study.</name><description>&lt;h4>Aims&lt;/h4>This study aimed to evaluate the risk of hip/femur fractures during the initiation period of α-adrenoceptor blocker therapy using the National Health Insurance claims database, Taiwan, with a self-controlled case series design.&lt;h4>Methods&lt;/h4>All male beneficiaries aged over 50 years as of 2007, who were incident users of α-adrenoceptor blockers and also had a diagnosis of hip/femur fracture within the 2007-2009 study period were identified. The first day when the α-adrenoceptor blocker was prescribed was set as the index date. We partitioned the initial 21 day period following the index date as the post-exposure risk period 1, days 22-60 after the index date as the post-exposure risk period 2, the 21 day period prior to the index date as the pre-exposure risk period 1 and day</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Nov</publication><modification>2025-04-06T19:45:31.106Z</modification><creation>2019-03-27T02:01:14Z</creation></dates><accession>S-EPMC4631193</accession><cross_references><pubmed>25924025</pubmed><doi>10.1111/bcp.12671</doi></cross_references></HashMap>